GSA Capital Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.44M | Buy |
|
|||||
|
2025
Q2 | $999K | Sell |
|
|||||
|
2025
Q1 | $2.09M | Buy |
|
|||||
|
2024
Q4 | $1.24M | Sell |
|
|||||
|
2024
Q3 | $2.17M | Sell |
|
|||||
|
2024
Q2 | $2.25M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.07M | Sell |
|
|||||
|
2023
Q3 | $1.36M | Buy |
|
|||||
|
2023
Q2 | $504K | Sell |
|
|||||
|
2023
Q1 | $1.28M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $241K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $591K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $816K | Buy |
|
|||||
|
2020
Q4 | $78K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $189K | Sell |
|
|||||
|
2020
Q1 | $277K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $329K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $69K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $430K | Sell |
|
|||||
|
2014
Q3 | $535K | Buy |
|